logo
Share SHARE
FONT-SIZE Plus   Neg

NovaBay Pharma, Virbac Animal Health Ink Option Deal For Aganocide Compounds

NovaBay Pharmaceuticals Inc. (NBY) said it has reached a feasibility and option agreement with Virbac Animal Health for the development and potential commercialization of Aganocides for a number of veterinary use. As per the deal, NovaBay would receive an upfront payment plus additional support for research and development.

Virbac would conduct veterinary studies using NovaBay's Aganocide compounds in order to assess feasibility for treating several veterinary indications, and it would have the option to license exclusive worldwide rights to market Aganocides for one or more of these indications. If exercised, NovaBay may receive additional payments, including an exercise fee as well as development and pre-commercial milestones for a line of veterinary products. Also, NovaBay would receive royalties on sales of any commercialized Aganocide products to arise from this agreement.

NovaBay is developing its first-in-class, non-antibiotic, anti-infective Aganocide compounds for the topical treatment and prevention of a wide variety of bacterial, viral and fungal infections.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of Electrolux AB were gaining around 5 percent in the trading in Sweden after the home appliances giant reported higher profit and sales in its first quarter. President and CEO Jonas Samuelson said, "We will continue to drive profitable growth by creating best-in-class consumer experiences which are supported by innovation and operational excellence." Automaker General Motors Co. reported Friday significantly higher profit in its first-quarter with strong growth in automotive and financial sales and higher volume. Earnings per share and revenues topped market estimates. Further, the company backed its fiscal 2017 adjusted earnings view. In pre-market activity on the NYSE, GM shares were gaining 1.94 percent. Exxon Mobil Corp. (XOM) reported estimated first-quarter net income to company of $4.01 billion, or $0.95 per share, compared with $1.81 billion or $0.43, a year earlier, resulting from improvements in commodity prices, cost management and refining operations. On average, 21 analysts polled by Thomson...
comments powered by Disqus
Follow RTT